Section 2: Selection, Procurement and Distribution

2SPD-007

COMPARATIVE EFFECTIVENESS AND SAFETY OF EVEROLIMUS AND AXITINIB AS SECOND-LINE THERAPY IN METASTATIC RENAL CELL CARCINOMA

2SPD-003

MAGNETIC DOUBLE PIGTAIL STENT: AN ECONOMICALLY INTERESTING INNOVATIVE DEVICE?

2SPD-031

ECONOMIC ANALYSIS OF THE PHARMACEUTICAL SUPPLY TO A SOCIO-SANITARY CENTRE FROM THE HOSPITAL PHARMACY SERVICE

2SPD-030

DRUG SHORTAGE IMPACT ON PATIENT CARE: AN INCREASING HEALTHCARE PROBLEM

2SPD-009

IMPLEMENTATION OF A SPECIFIC CIRCUIT OF HAZARDOUS DRUGS IN A PHARMACY DEPARTMENT

2SPD-004

ANALYSIS OF PIPERACILLIN/TAZOBACTAM USE DURING ITS WORLDWIDE SHORTAGE

2SPD-028

COMPARATIVE STUDY OF TWO METHODS OF UNITDOSE PACKAGING: ETICONFORM® AND EURAF®

2SPD-024

UNIT DOSE SYSTEM EVALUATION

2SPD-018

DETERMINATION OF TRENDS OF PRESCRIPTION AND USE OF OFF-LABEL DRUGS IN PAEDIATRIC UNITS AT A HIGH COMPLEXITY HOSPITAL

2SPD-015

ANALYSIS OF EXPENDITURE ON ORPHAN DRUGS ACCORDING TO THE DIAGNOSIS

2SPD-012

BUDGETARY IMPACT OF ULTRA-RARE DISEASES IN A THIRD-LEVEL HOSPITAL

2SPD-011

LEAD-TIME FOR DELIVERY OF CHEMOTHERAPIES AT DAY HOSPITAL: DIFFICULTIES OF A CHEMOTHERAPY COMPOUNDING UNIT WITH TWO DAY HOSPITALS ON TWO SITES

2SPD-010

ASSESSMENT OF PERTUZUMAB USE FOR HER2- POSITIVE BREAST CANCER TREATMENT

2SPD-002

ECONOMIC ASPECTS OF THE USE OF FLUIDS IN SEPSIS

Pages